NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 146 filers reported holding NEKTAR THERAPEUTICS in Q3 2014. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $823,000 | +32.3% | 59,876 | +65.0% | 0.00% | 0.0% |
| Q4 2015 | $622,000 | -2.2% | 36,290 | -28.6% | 0.00% | 0.0% |
| Q2 2015 | $636,000 | +3247.4% | 50,800 | +2904.1% | 0.00% | – |
| Q1 2015 | $19,000 | -99.0% | 1,691 | -98.6% | 0.00% | -100.0% |
| Q4 2014 | $1,829,000 | +135.7% | 119,091 | +85.2% | 0.00% | +200.0% |
| Q3 2014 | $776,000 | +42.4% | 64,300 | +26.6% | 0.00% | 0.0% |
| Q2 2014 | $545,000 | +51.0% | 50,800 | +47.1% | 0.00% | 0.0% |
| Q3 2013 | $361,000 | +27.6% | 34,532 | +40.8% | 0.00% | 0.0% |
| Q2 2013 | $283,000 | – | 24,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 750,000 | $930,000 | 0.85% |
| Deep Track Capital, LP | 17,875,498 | $22,165,618 | 0.66% |
| Acuitas Investments, LLC | 879,904 | $1,091,081 | 0.58% |
| TCG Crossover Management, LLC | 4,000,000 | $4,960,000 | 0.52% |
| Almitas Capital LLC | 920,225 | $1,141,079 | 0.47% |
| Monaco Asset Management SAM | 2,166,432 | $2,686,376 | 0.43% |
| Shay Capital LLC | 1,840,377 | $2,282,067 | 0.32% |
| Nantahala Capital Management | 4,110,000 | $5,096,400 | 0.30% |
| Ikarian Capital, LLC | 1,312,405 | $1,627,382 | 0.28% |
| SAMLYN CAPITAL, LLC | 9,457,887 | $11,727,781 | 0.20% |